So, on Monday 29 January, Panorama promises to reveal the secret trail of internal emails which show how GSK manipulated the results of Seroxat trials in children for its own commercial gain.
The documents also reveal how the company continued to deny safety problems with the drug despite three investigations by Panorama reporter Shelley Jofre.
Almost a year ago there was another leak of secret data, this time from Dr Peter Breggin.
Each and every time more damning information becomes public, we are asked to believe that Ian Hudson did not have full knowledge of ALL the trials and data that appertained to Seroxat. Hudson was Glaxo’s Worldwide Director of Safety and had, in his own words, “a significant involvement in Paroxetine” (Seroxat).
What adds insult to injury is that this is the same Ian Hudson who now heads up the drug licensing operations of the UK regulator, the MHRA.
This is also the same Ian Hudson who decided not to appear to be questioned by the House of Commons Health Select Committee – although several senior figures from the Medicines and Healthcare Products Regulatory Agency attended the session, the committee said that it would also have liked to have heard evidence from Ian Hudson. MPs wanted to question Dr Hudson about the company’s drug paroxetine (marketed as Seroxat in Britain and as Paxil in the United States).They were particularly interested in evidence concerning the safety and efficacy of the drug in people under the age of 18.
And so we come back to the subject of the new Panorama programme which shows how GSK manipulated the results of Seroxat trials in children for its own commercial gain…
I’d like someone to ask Dr Ian Hudson where he was and what he was doing when all this was going on at Glaxo – when he had “significant involvement in Paroxetine” (Seroxat) and he was Glaxo’s Worldwide Director of Safety.
Panorama, Monday 29 January 2007, BBC One 20.30.